Article
Immunohistochemical Study Using Monoclonal VE1 Antibody Can Substitute the Molecular Tests for Apprehension of BRAF V600E Mutation in Patients with Non-small-Cell Lung Carcinoma.
Analytical cellular pathology (Amsterdam) - 1 Jan 2019
Karbel Hadeel Abdul Elah, Ejam Sura Salman, Naji Ali Zaki
Abstract excerpt
In patients with non-small-cell lung carcinoma (NSCLC), the analysis of BRAF V600E mutation has become more and more applied since the introduction of many mutation-targeted medications. In this regard, the advantage of immunohistochemistry (IHC) as a reliable diagnostic test substitute to other...
Topics
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
- Carcinoma, Non-Small-Cell Lung
- Female
- Humans
- Immunohistochemistry
- Lung Neoplasms
- Male
- Middle Aged
- Mutation
- Proto-Oncogene Proteins B-raf